Molecular Characteristics of Macrolide Resistance in Treponema pallidum from Patients with Latent Syphilis in Xinjiang, China

References

• Liu AY, Zang WJ, Yuan LL, et al. Latent syphilis among inpatients in an Urban Area of China. Glob J Health Sci. 2014;7(3):249–253. doi:10.5539/gjhs.v7n3p249
   PubMedGoogle Scholar
• Zhang X, Hou F, Li X, et al. Study of surveillance data for class B notifiable disease in China from 2005 to 2014. Int J Infect Dis. 2016;48:7–13. doi:10.1016/j.ijid.2016.04.010
   PubMed Web of Science ®Google Scholar
• Chen YX, Jie L, Yi Z. Tredds in the epidemiology of sexually transmitted disease, Acquired Immune Deficiency Syndrome(AIDS), gonorrhea, and syphilis, in the 31 provinces of Mainland China. Med Sci Monit. 2019;25:5657–5665. doi:10.12659/MSM.915732
   PubMed Web of Science ®Google Scholar
• Bourgeois G, Grange P, Terrier CSP, et al. Azithromycin resistance in Treponema pallidum in Reunion Island: a cross-sectional study. Ann Dermatol Venereol. 2021;148(3):249–253. doi:10.1016/j.annder.2020.12.003
   Web of Science ®Google Scholar
• Venter JME, Müller EE, Mahlangu MP, et al. Treponema pallidum macrolide resistance and molecular epidemiology in Southern Africa, 2008 to 2018. J Clin Microbiol. 2021;59(10):e0238520. doi:10.1128/JCM.02385-20
   PubMed Web of Science ®Google Scholar
• Molini BJ, Tantalo LC, Sahi SK, et al. Macrolide resistance in Treponema palidum correlates with 23S rDNA mutations in recently isolated clincal strains. Sex Transm Dis. 2016;43(9):579–583. doi:10.1097/OLQ.0000000000000486
   PubMed Web of Science ®Google Scholar
• Posana Y, Yasmon A, Indriatmi W, et al. Detection of A2058G and A2059G on the 23S rRNA gene by multiplex nested PCR to identify Treponema palidum resistance to azithromycin in Indonesia. Jpn J Infect Dis. 2022;75:355–360. doi:10.7883/yoken.JJID.2021.738
   PubMed Web of Science ®Google Scholar
• Lu H, Li K, Gong W, et al. High frequency of the 23S rRNA A2058G mutation of Treponema pallidum in Shanghai is associated with a current strategy for the treatment of syphilis. Emerg Microbes Infect. 2015;4(2):e10. doi:10.1038/emi.2015.10
   PubMedGoogle Scholar
• Xiao Y, Liu S, Liu Z, et al. Molecular subtyping and surveillance of resistance genes in Treponema pallidum DNA from patients with secondary and latent Syphilis in Hunan, China. Sex Transm Dis. 2016;43(5):310–316. doi:10.1097/OLQ.0000000000000445
   PubMed Web of Science ®Google Scholar
• Li Z, Hou J, Zheng R, et al. Two mutations associated with macrolide resistance in Treponema pallidum in Shangdong, China. J Clin Microbiol. 2013;51(12):4270–4271. doi:10.1128/JCM.01261-13
   PubMed Web of Science ®Google Scholar
• Liu D, He SM, Zhu XZ, et al. Molecular characterization based on MLST and ECDC typing schemes and antibiotic resistance analyses of Treponema pallidum subsp. Pallidum in Xiamen, China. Front Cell Infect Microbiol. 2021;10:618747. doi:10.3389/fcimb.2020.618747
   PubMed Web of Science ®Google Scholar
• Zondag HCA, Cornelissen AR, Dam AP, et al. Molecular diversity of Treponema pallidum subspecies pallidum isolates in Amsterdam, the Netherlands. Sex Transm Infect. 2020;96(3):223–226. doi:10.1136/sextrans-2019-054044
   PubMed Web of Science ®Google Scholar
• Khairullin R, Vorobyev D, Obukhov A, et al. Syphillis epidemiology in 1994–2013, molecular epidemiological strain typing and determination of macrolide resistance in Treponema pallidum in 2013–2014 in Tuva Republic, Russia. APMIS. 2016;124(7):595–602. doi:10.1111/apm.12541
   PubMed Web of Science ®Google Scholar
• Nishiki S, Arima Y, Kanai M, et al. Epidemiology, molecular strain types, and macrolide resistance of Treponema pallidum in Japan, 2017–2018. J Infect Chemother. 2020;26(10):1042–1047. doi:10.1016/j.jiac.2020.05.022
   PubMed Web of Science ®Google Scholar
• Fernández-Naval C, Arando M, Espasa M, et al. Enhanced molecular typing and macrolide and tetracycline-resistance mutations of Treponema pallidum in Barcelona. Future Microbiol. 2019;14(13):1099–1108. doi:10.2217/fmb-2019-0123
   PubMed Web of Science ®Google Scholar
• Workowski KA, Bolan. GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR–03):1–137.
   PubMed Web of Science ®Google Scholar
• Martin IE, Tsang RSW, Sutherland K, et al. Molecular characterization of syphilis in patients in Canada: azithromycin resistance and detection of Treponema pallidum DNA in whole-blood samples versus ulcerative swabs. J Clin Microbiol. 2009;47(6):1668–1673. doi:10.1128/JCM.02392-08
   PubMed Web of Science ®Google Scholar
• Sheila A, Godornes C, Barbara J, et al. Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med. 2004;351(2):154–158. doi:10.1056/NEJMoa040216
   PubMed Web of Science ®Google Scholar
• Matějková P, Flasarová M, Zákoucká H, et al. Macrolide treatment failure in a case of secondary syphilis: a novel A2059G mutation in the 23S rRNA gene of Treponema pallidum subsp. pallidum. J Med Microbiol. 2009;58(Pt6):832–836. doi:10.1099/jmm.0.007542-0
   PubMedGoogle Scholar
• Wang C, Cheng Y, Liu B, et al. Sensitive detection of Treponema pallidum DNA from the whole blood of patients with syphilis by the nested PCR assay. Emerg Microbes Infect. 2018;7(1):83. doi:10.1038/s41426-018-0085-2
   PubMedGoogle Scholar
• Kenyon C. Prevalence of macrolide resistance in Treponema pallidum is associated with macrolide consumption. J Med Microbiol. 2019;68(2):119–123. doi:10.1099/jmm.0.000885
   PubMed Web of Science ®Google Scholar
• Marra CM, Colina AP, Godornes C, et al. Antibiotic selection may contribute to increases in macrolide-resistant Treponema pallidum. J Infect Dis. 2006;194:1771–1773. doi:10.1086/509512
   PubMed Web of Science ®Google Scholar